Xcout IntelCeriBell, Inc.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Subscribe to see CeriBell, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CeriBell, Inc. at a glance
CeriBell, Inc. is a healthtech company headquartered in Sunnyvale, United States. It is publicly listed (CBLL) with a market capitalisation of $961M. Xcout tracks 28 named people at CeriBell, Inc., including Scott Blumberg (Chief Financial Officer). Xcout recorded 75 job postings from CeriBell, Inc. in the last 90 days.
CeriBell, Inc. leadership
- Scott BlumbergChief Financial Officer
- Raymond WooChief Technology Officer
- Joseph S. ManniChief Revenue Officer
- Sean ManniChief Revenue Officer
- Louisa DanielsGeneral Counsel
- Xingjuan ChaoCo-Founder, President, Chief Executive Officer & Director
22 more named people on record for CeriBell, Inc., with roles, board committees and tenure — see the full roster →
CeriBell, Inc. funding rounds before its IPO
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C-1 | $100.4M | 6 named | |
| Series C | $102.5M | 1 named | |
| Series B | $35M | 3 named |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at CeriBell, Inc.
Xcout recorded 75 job postings from CeriBell, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see CeriBell, Inc.'s hiring signals →
Hiring vs the trend
Based on 63 job postings in the last 8 weeks (24 Aug – 18 Oct 2026), compared with 181 scale-up healthcare companies.
This describes a hiring pattern — how often CeriBell, Inc.’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Investors
CeriBell, Inc. competitors
A few of CeriBell, Inc.'s closest competitors — see the full list of competitors and alternatives →
Based in Santa Monica, California, Kneevoice Inc. is a medical device company pioneering new ways to diagnose medical conditions by utilizing neural-networks for cartilage auscultation.
Neuro-Vascular Research & Design Corp develops artificial intelligence-powered intraoperative neuromonitoring (IONM) platforms and precision hardware for surgical environments. The company's technology provides real-time data analysis to help healthcare providers detect neurological risks and guide surgical decision-making during high-risk surgeries.
Forest Devices, Inc. is a Pittsburgh-based medical device startup founded in 2015 that is developing AlphaStroke, a diagnostic device designed for the rapid detection of stroke.
Neurosoft manufactures and supplies medical equipment and software focused on neurophysiology, functional diagnostics, audiology, and rehabilitation. The company serves healthcare providers, clinics, and veterinary professionals with diagnostic devices, monitoring systems, and related educational resources.
Eko Health is a U.S. digital health company that develops smart stethoscopes and clinical software using artificial intelligence to help detect heart and lung conditions. Its products are intended for healthcare professionals, including primary care clinicians and cardiologists.
AI Diagnostics is a medical equipment manufacturing company that develops affordable, easy-to-use AI-powered digital stethoscopes for early detection and screening of diseases like tuberculosis.
Get CeriBell, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about CeriBell, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CeriBell, Inc. in Xcout Intel
- 28 named people with titles, LinkedIn and board committees
- 3 funding rounds before the IPO with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access